FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2017479791> ?p ?o ?g. }

• W2017479791 endingPage "3891" @default.
• W2017479791 startingPage "3884" @default.
• W2017479791 abstract "Abstract Objective Glomerular mesangial cells are active participants in the pathogenesis of lupus glomerulonephritis (GN). Thus, targeted delivery of therapeutic agents to mesangial cells would be an attractive approach to treatment. However, lack of known unique mesangial cell surface markers has hampered this process. This study was undertaken in a mouse model of lupus GN to identify mesangial markers and to develop a system for targeted drug delivery to the glomerulus. Methods Based on previous observations, α8 integrin expressed on the surface of glomerular mesangial cells was selected as a target molecule for delivery. Two mouse strains susceptible to lupus GN, NZM2328 and (NZM2328 × NOD)F 1 , were studied. Glomerular expression of α8 integrin in normal and nephritic mice was confirmed by immunofluorescence and quantitative polymerase chain reaction analysis. Liposomes were formulated and conjugated with an anti–α8 integrin antibody. These immunoliposomes were loaded with DiI, a red fluorescent dye, to allow tracking in vivo, and injected into the tail vein of female mice at different ages. Specificity of targeting was studied by fluorescence microscopy and flow cytometry. Results Expression of α8 integrin was observed in the glomeruli of normal and nephritic mice. Anti–α8 integrin immunoliposomes were detected in the glomerulus and glomerular mesangial cells after tail vein injection in normal and nephritic mice. Delivery of DiI by anti–α8 integrin immunoliposomes was tissue specific, being observed predominantly in the glomeruli, with some nonspecific uptake by CD11b cells. Conclusion These findings are the first demonstration of specific delivery of anti–α8 integrin immunoliposomes to the mesangium following tail vein injection in mice. Anti–α8 integrin immunoliposomes thus offer a novel approach for targeted drug therapy in lupus and other glomerular diseases." @default.
• W2017479791 created "2016-06-24" @default.
• W2017479791 creator A5007094753 @default.
• W2017479791 creator A5032819424 @default.
• W2017479791 creator A5050637048 @default.
• W2017479791 creator A5065844095 @default.
• W2017479791 date "2008-11-26" @default.
• W2017479791 modified "2023-10-16" @default.
• W2017479791 title "Anti-α8 integrin immunoliposomes in glomeruli of lupus-susceptible mice: A novel system for delivery of therapeutic agents to the renal glomerulus in systemic lupus erythematosus" @default.
• W2017479791 cites W1590991291 @default.
• W2017479791 cites W1594826226 @default.
• W2017479791 cites W1846501109 @default.
• W2017479791 cites W1903673679 @default.
• W2017479791 cites W1986129921 @default.
• W2017479791 cites W1993756042 @default.
• W2017479791 cites W2013920567 @default.
• W2017479791 cites W2014365674 @default.
• W2017479791 cites W2018509996 @default.
• W2017479791 cites W2021724108 @default.
• W2017479791 cites W2036571447 @default.
• W2017479791 cites W2043526660 @default.
• W2017479791 cites W2047577279 @default.
• W2017479791 cites W2053555638 @default.
• W2017479791 cites W2066126648 @default.
• W2017479791 cites W2071522059 @default.
• W2017479791 cites W2076340325 @default.
• W2017479791 cites W2083743409 @default.
• W2017479791 cites W2099359513 @default.
• W2017479791 cites W2103344269 @default.
• W2017479791 cites W2103678678 @default.
• W2017479791 cites W2108836709 @default.
• W2017479791 cites W2109843381 @default.
• W2017479791 cites W2110318152 @default.
• W2017479791 cites W2126206894 @default.
• W2017479791 cites W2131355712 @default.
• W2017479791 cites W2145033838 @default.
• W2017479791 cites W2168208695 @default.
• W2017479791 cites W2253820652 @default.
• W2017479791 doi "https://doi.org/10.1002/art.24026" @default.
• W2017479791 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2678908" @default.
• W2017479791 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19035491" @default.
• W2017479791 hasPublicationYear "2008" @default.
• W2017479791 type Work @default.
• W2017479791 sameAs 2017479791 @default.
• W2017479791 citedByCount "56" @default.
• W2017479791 countsByYear W20174797912012 @default.
• W2017479791 countsByYear W20174797912013 @default.
• W2017479791 countsByYear W20174797912015 @default.
• W2017479791 countsByYear W20174797912016 @default.
• W2017479791 countsByYear W20174797912017 @default.
• W2017479791 countsByYear W20174797912018 @default.
• W2017479791 countsByYear W20174797912019 @default.
• W2017479791 countsByYear W20174797912020 @default.
• W2017479791 countsByYear W20174797912021 @default.
• W2017479791 countsByYear W20174797912022 @default.
• W2017479791 countsByYear W20174797912023 @default.
• W2017479791 crossrefType "journal-article" @default.
• W2017479791 hasAuthorship W2017479791A5007094753 @default.
• W2017479791 hasAuthorship W2017479791A5032819424 @default.
• W2017479791 hasAuthorship W2017479791A5050637048 @default.
• W2017479791 hasAuthorship W2017479791A5065844095 @default.
• W2017479791 hasBestOaLocation W20174797911 @default.
• W2017479791 hasConcept C126322002 @default.
• W2017479791 hasConcept C142724271 @default.
• W2017479791 hasConcept C159654299 @default.
• W2017479791 hasConcept C170493617 @default.
• W2017479791 hasConcept C171779818 @default.
• W2017479791 hasConcept C195687474 @default.
• W2017479791 hasConcept C203014093 @default.
• W2017479791 hasConcept C2776912625 @default.
• W2017479791 hasConcept C2777146197 @default.
• W2017479791 hasConcept C2778236600 @default.
• W2017479791 hasConcept C2779131090 @default.
• W2017479791 hasConcept C2779134260 @default.
• W2017479791 hasConcept C2779561371 @default.
• W2017479791 hasConcept C2779912601 @default.
• W2017479791 hasConcept C2780091579 @default.
• W2017479791 hasConcept C2780368995 @default.
• W2017479791 hasConcept C3018920779 @default.
• W2017479791 hasConcept C553184892 @default.
• W2017479791 hasConcept C71924100 @default.
• W2017479791 hasConceptScore W2017479791C126322002 @default.
• W2017479791 hasConceptScore W2017479791C142724271 @default.
• W2017479791 hasConceptScore W2017479791C159654299 @default.
• W2017479791 hasConceptScore W2017479791C170493617 @default.
• W2017479791 hasConceptScore W2017479791C171779818 @default.
• W2017479791 hasConceptScore W2017479791C195687474 @default.
• W2017479791 hasConceptScore W2017479791C203014093 @default.
• W2017479791 hasConceptScore W2017479791C2776912625 @default.
• W2017479791 hasConceptScore W2017479791C2777146197 @default.
• W2017479791 hasConceptScore W2017479791C2778236600 @default.
• W2017479791 hasConceptScore W2017479791C2779131090 @default.
• W2017479791 hasConceptScore W2017479791C2779134260 @default.
• W2017479791 hasConceptScore W2017479791C2779561371 @default.
• W2017479791 hasConceptScore W2017479791C2779912601 @default.
• W2017479791 hasConceptScore W2017479791C2780091579 @default.
• W2017479791 hasConceptScore W2017479791C2780368995 @default.
• W2017479791 hasConceptScore W2017479791C3018920779 @default.

• next